NCT05441475 2026-02-25
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
Abbisko Therapeutics Co, Ltd
Phase 2 Enrolling by invitation
Clinical Trials
3 trialsNCT07046832 2025-07-02
Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
MediView XR, Inc.
Phase NA Enrolling by invitation
NCT06712017 2024-12-05
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
GrandPharma (China) Co., Ltd.
Enrolling by invitation